NCT00651833 2024-09-03
Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer
Taiho Oncology, Inc.
Phase 2 Completed
Taiho Oncology, Inc.
Taiho Oncology, Inc.
National Cancer Institute, Naples
Gachon University Gil Medical Center